| Literature DB >> 32198315 |
Abstract
Parallel to the application of new PET radiopharmaceuticals for pheochromocytoma and paraganglioma (collectively named PPGLs) imaging, several studies have increased our understanding on their biology, genetics, metabolomics, and embryologic origin. In this review, we highlight the current relationship between genotypes and molecular imaging phenotypes. Additionally, we summarize the referral guidelines for imaging of PPGL patients with or without knowledge of their genetic background.Entities:
Keywords: Key Terms: pheochromocytoma; PET/CT; genetics; paragangliomas; precision medicine; radiopharmaceuticals
Year: 2020 PMID: 32198315 DOI: 10.2967/jnumed.120.245613
Source DB: PubMed Journal: J Nucl Med ISSN: 0161-5505 Impact factor: 10.057